Citric acid-based elastomers provide a biocompatible interface for vascular grafts

Journal of Biomedical Materials Research - Part A

Volumn 93, Issue 1, 2010, Pages 314-324

  Kibbe, Melina R ^a   Martinez, Janet ^a   Popowich, Daniel A ^a   Kapadia, Muneera R ^a   Ahanchi, Sadaf S ^a   Aalami, Oliver O ^a   Jiang, Qun ^a   Webb, Antonio R ^b   Yang, Jian ^c   Carroll, Timothy ^a   Ameer, Guillermo A ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Northwestern University   (United States)

^c The University of Texas at Arlington   (United States)

Author keywords

Bypass graft; Endothelial cell; ePTFE; Neointimal hyperplasia; Polymer; Prosthetic

Indexed keywords

BIOCOMPATIBLE INTERFACES; BIOCOMPATIBLE SURFACES; BIODEGRADABLE ELASTOMERS; BYPASS GRAFT; BYPASS GRAFTING; CAROTID ARTERY; CONTACTING SURFACES; EPTFE; EXPANDED POLYTETRAFLUOROETHYLENE (EPTFE); MAGNETIC RESONANCE ANGIOGRAPHY; NEOINTIMAL HYPERPLASIA; PATENCY RATES; STENOSES; SURFACE MODIFICATION; VASCULAR GRAFTS; VASCULATURE;

ANGIOGRAPHY; BIOLOGICAL MATERIALS; BLOOD VESSEL PROSTHESES; ENDOTHELIAL CELLS; GRAFTING (CHEMICAL); GROWTH KINETICS; RESONANCE; RUBBER; SCAFFOLDS; SCANNING ELECTRON MICROSCOPY; SELF ASSEMBLY; ULTRASONIC IMAGING; ULTRASONOGRAPHY;

GRAFTS;

CITRIC ACID; ELASTOMER; POLITEF; POLY(1,8 OCTANEDIOL CITRATE); POLYMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BLOOD VESSEL GRAFT; CAROTID ARTERY FLOW; CELL INFILTRATION; CONTROLLED STUDY; DIGITAL SUBTRACTION ANGIOGRAPHY; ECHOGRAPHY; END TO SIDE ANASTOMOSIS; FIBER; HEMODYNAMICS; HYPERPLASIA; LEUKOCYTE; MAGNETIC RESONANCE ANGIOGRAPHY; MONOCYTE; NONHUMAN; SCANNING ELECTRON MICROSCOPY; SWINE; VASCULAR PATENCY;

ANIMALS; BIOCOMPATIBLE MATERIALS; BLOOD VESSEL PROSTHESIS; BLOOD VESSELS; CITRATES; ELASTOMERS; ENDOTHELIUM, VASCULAR; INFLAMMATION; MACROPHAGES; MICROSCOPY, ELECTRON, SCANNING; MONOCYTES; POLYMERS; SUS SCROFA; THROMBOSIS;

EID: 77649204562     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32537     Document Type: Article

References (35)

1. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:e69-e171.
2. Chew DK, Nguyen LL, Owens CD, Conte MS, Whittemore AD, Gravereaux EC, Menard MT, Belkin M. Comparative analysis of autogenous infrainguinal bypass grafts in African Americans and Caucasians: The association of race with graft function and limb salvage. J Vasc Surg 2005;42:695-701.
3. Green RM, Abbott WM, Matsumoto T, Wheeler JR, Miller N, Veith FJ, Money S, Garrett HE. Prosthetic above-knee femoropopliteal bypass grafting: five-year results of a randomized trial. J Vasc Surg 2000;31:417-425.
4. Eagleton MJ, Ouriel K, Shortell C, Green RM. Femoral-infrapopliteal bypass with prosthetic grafts. Surgery 1999;126:759-764.
5. Abbott WM, Megerman J, Hasson JE, Litalien G, Warnock DF. Effect of compliance mismatch on vascular graft patency. J Vasc Surg J Vasc Surg 1987;5:376-382.
6. Clowes AW, Gown AM, Hanson SR, Reidy MA. Mechanisms of arterial graft failure. 1. Role of cellular proliferation in early healing of Ptfe prostheses. Am J Pathol 1985;118:43-54.
7. Clowes AW, Kirkman TR, Clowes MM. Mechanisms of arterial graft failure. II. Chronic endothelial and smooth muscle cell proliferation in healing polytetrafluoroethylene prostheses. J Vasc Surg 1986;3:877-884.
8. Loth F, Jones SA, Zarins CK, Giddens DP, Nassar RF, Glagov S, Bassiouny HS. Relative contribution of wall shear stress and injury in experimental intimal thickening at PTFE end-to-side arterial anastomoses. J Biomech Eng 2002;124:44-51.
9. Kidane AG, Salacinski H, Tiwari A, Bruckdorfer KR, Seifalian AM. Anticoagulant and antiplatelet agents: Their clinical and device application(s) together with usages to engineer surfaces. Biomacromolecules 2004;5:798-813.
10. Ascer E, Gennaro M, Pollina RM, Ivanov M, Yorkovich WR, Ivanov M, Lorensen E. Complementary distal arteriovenous fistula and deep vein interposition: A five-year experience with a new technique to improve infrapopliteal prosthetic bypass patency. J Vasc Surg 1996;24:134-143.
11. Batson RC, Sottiurai VS, Craighead CC. Linton patch angioplasty. An adjunct to distal bypass with polytetrafluoroethylene grafts. Ann Surg 1984;199:684-693.
12. Griffiths GD, Nagy J, Black D, Stonebridge PA. Randomized clinical trial of distal anastomotic interposition vein cuff in infrainguinal polytetrafluoroethylene bypass grafting. Br J Surg 2004;91:560-562.
13. Stonebridge PA, Prescott RJ, Ruckley CV. Randomized trial comparing infrainguinal polytetrafluoroethylene bypass grafting with and without vein interposition cuff at the distal anastomosis. The Joint Vascular Research Group. J Vasc Surg 1997;26:543-550.
14. Taylor RS, Loh A, Mcfarland RJ, Cox M, Chester JF. Improved Technique for Polytetrafluoroethylene Bypass-Grafting - Long-Term Results Using Anastomotic Vein Patches. Br J Surg 1992;79:348-354.
15. Kapadia MR, Popowich DA, Kibbe MR. Modified prosthetic vascular conduits. Circulation 2008;117:1873-1882.
16. Yang J, Motlagh D, Allen JB, Webb AR, Kibbe MR, Aalami O, Kapadia M, Carroll TJ, Ameer GA. Modulating expanded polytetrafluoroethylene vascular graft host response via citric acid-based biodegradable elastomers. Adv Mater 2006; 18:1493-1498.
17. Yang J, Webb AR, Ameer GA. Novel citric acid-based biodegradable elastomers for tissue engineering. Adv Mater 2004;16:511-516.
18. Yang J, Webb AR, Pickerill SJ, Hageman G, Ameer GA. Synthesis and evaluation of poly(diol citrate) biodegradable elastomers. Biomaterials 2006;27:1889-1898.
19. Motlagh D, Allen J, Hoshi R, Yang J, Lui K, Ameer G. Hemocompatibility evaluation of poly(diol citrate) in vitro for vascular tissue engineering. J Biomed Mater Res A 2007;82:907-916.
20. Kapadia MR, Aalami OO, Najjar SF, Jiang Q, Murar J, Lyle B, Eng JW, Kane B, Carroll T, Cahill PM, Kibbe MR. A reproducible porcine ePTFE arterial bypass model for neointimal hyperplasia. J Surg Res 2008;148:230-237.
21. Allen J, Khan S, Serrano MC, Ameer G. Characterization of porcine circulating progenitor cells: Toward a functional endothelium. Tissue Eng Part A 2008;14:183-194.
22. Cagiannos C, Abul-Khoudoud OR, DeRijk W, Shell DH, Jennings LK, Tolley EA, Handorf CR, Fabian TC. Rapamycincoated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model. J Vasc Surg 2005;42:980-988.
23. Lee BH, Nam HY, Kwon T, Kim SJ, Kwon GY, Jeon HJ, Lim HJLWK, Park JS, Ko JY, Kim DJ. Paclitaxel-coated expanded polytetrafluoroethylene haemodialysis grafts inhibit neointimal hyperplasia in porcine model of graft stenosis. Nephrol Dial Transplant 2006;21:2432-2438.
24. Zilla P. Endothelialization of vascular grafts. Curr Opin Cardiol 1991;6:877-886.
25. Zilla P, Fasol R, Deutsch M, Fischlein T, Minar E, Hammerle A, Krupicka O, Kadletz M. Endothelial-cell seeding of polytetrafluoroethylene vascular grafts in humans - a preliminary-report. J Vasc Surg 1987;6:535-541.
26. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-2130.
27. Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007; 356:1009-1019.
28. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007;356:989-997.
29. Maisel WH. Unanswered questions-drug-eluting stents and the risk of late thrombosis. N Engl J Med 2007;356:981-984.
30. Wernick MH, Jeremias A, Carrozza JP. Drug-eluting stents and stent thrombosis: A cause for concern? Coronary Artery Dis 2006;17:661-665.
31. Murray-Wijelath J, Lyman DJ, Wijelath ES. Vascular graft healing. III. FTIR analysis of ePTFE graft samples from implanted bigrafts. J Biomed Mater Res B Appl Biomater 2004;70B:223-232.
32. Shindo S, Motohashi S, Katsu M, Kaga S, Inoue H, Matsumoto M. Coated prostheses are associated with prolonged inflammation in aortic surgery: A cost analysis. Artif Organs 2008;32:183-187.
33. Zippel R, Wilhelm L, Hoene A, Walschus U, Ueberrueck T, Schlosser M. Local tissue reaction and differentiation of the prosthesis-specific antibody response following functional implantation of vascular grafts in pigs. J Biomed Mater Res B Appl Biomater 2008;85B:334-342.
34. Walpoth BH, Zammaretti P, Cikirikcioglu M, Khabiri E, Djebaili MK, Pache JC, Tille JC, Aggoun Y, Morel D, Kalangos A, Hubbell JA, Zisch AH. Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular endothelial growth factor in the pig carotid artery interposition model. J Thorac Cardiovasc Surg 2007;133:1163-1170.
35. Hoshi RA, Behl S, Ameer GA. Biomedical materials: Nanoporous biodegradable elastomers. Adv Mater 2009; 21:188-192.